Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Construction of multifunctional nanozymes with amplified immunogenic death effect as a long-term anti-tumor nanoplatform

Biomaterials Advances(2025)10.1016/j.bioadv.2025.214336Source: DataRank Database

Construction of multifunctional nanozymes with amplified immunogenic death effect as a long-term anti-tumor nanoplatform is a research paper published in Biomaterials Advances (2025). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

9 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.07)OA: closedTopics (57)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

you sasha ORCID,Jingyu Chen ORCID,Wang Ye ORCID,Jian Tian ORCID,Xiyue Feng

Live enrichment

PubMed:40344986 OpenAlex:https://openalex.org/W4410132932

Natural Science Foundation of Hubei Province

Grant: 2025ADF349

Huazhong University of Science and Technology

Hubei University

Key Laboratory for the Synthesis and Application of Organic Functional Molecules, Ministry of Education

National Institutes of Health

FWCI

3.07

Citation Percentile

0.9%

Citation Trend

2025

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S2772950825001633?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2772950825001633?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.bioadv.2025.214336

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40344986

Fields of Study

Nanoplatforms for cancer theranosticsAdvanced Nanomaterials in CatalysisExtracellular vesicles in diseaseDoxorubicinAnimalsImmunogenic Cell DeathMiceHumansCopperCell Line, TumorAntineoplastic AgentsNanoparticlesNeoplasmsMice, Inbred BALB CFolic AcidMetal-Organic FrameworksManganese

MeSH Terms

Metal-Organic FrameworksImmunogenic Cell DeathAnimalsAntineoplastic AgentsCopperDoxorubicinFolic AcidHumansManganeseMice, Inbred BALB CNeoplasmsCell Line, TumorMiceNanoparticles

Keywords

Photothermal therapyCancer researchDoxorubicinChemistryGlutathioneImmunogenic cell deathTumor microenvironmentGlutathione peroxidasePeroxidaseImmune systemDual modeChemotherapyProgrammed cell deathMedicineImmunologyNanotechnologyMaterials scienceBiochemistryEnzymeTumor cellsInternal medicineApoptosissynergistic effectImmunogenic Cell Death (Icd)Mild Photothermal TherapyMultifunctional Nanozymes

Sustainable Development Goals

SDG 0: Good health and well-being

Construction of multifunctional nanozymes with amplified immunogenic death effect as a long-term anti-tumor nanoplatform

FAIR Checklist

Authors (9)

Funding (5 grants)

Impact

Open Access

Topics